OHB’s Post-Hype Hangover Deepens as Stock Clings to a Critical Technical Lifeline
Published on 07/28/2026 at 04:30 | Redaktion boerse-global.de
The narrative around OHB has shifted with breathtaking speed. Just months ago, the Bremen-based space and defence contractor was the darling of European markets, its shares propelled into the stratosphere by a geopolitical rearmament frenzy. Now, the stock is fighting for its footing at a level that would have seemed unthinkable back in May, and the cause is not a disappointing earnings miss but the mechanics of its own financing.
On Monday, OHB closed at €243.00, a staggering 64.68% below the all-time high of €688.00 reached in May. The decline has been so sharp that the shares now trade within a whisker — just 0.46% — of their 200-day moving average, currently pegged at €241.40. That line in the sand is the most closely watched technical marker for traders trying to decide whether this is a healthy consolidation or the beginning of something worse.
The trigger for the reversal was a €900 million capital measure executed in June and July. OHB issued new shares at a subscription price of €300, raising roughly €484 million in gross proceeds for the company. The remainder of the transaction allowed financial investor KKR to cash out a significant portion of its long-standing stake. The placement price itself represented a notable discount to the prevailing market rate, yet the stock promptly fell below that level in the aftermath — a development that market veterans read as a clear warning that demand for the enlarged share count was insufficient.
When a major insider sells after a multi-hundred-percent rally, retail and institutional investors alike tend to take notice. The message is uncomfortable: the growth story that drove the stock from obscurity to stardom may already be fully priced in, leaving only the cold arithmetic of valuation multiples to contend with.
Should investors sell immediately? Or is it worth buying OHB SE?
And those multiples remain a problem. At the May peak, the consensus price-to-earnings ratio for 2026 stood at nearly 190. Even after the correction, the stock is not cheap by conventional measures. That explains why, despite an intact operational outlook — a bulging order book, participation in the SpaceRISE consortium for the IRIS² satellite programme, and a new cooperation with MDA Space on autonomous lunar landings under the Argonaut initiative — the share price has struggled to regain its former momentum.
The chart tells a story of a market searching for a floor. The relative strength index sits at 34.4, indicating oversold conditions without flashing the kind of extreme readings that often precede a sharp bounce. The 50-day moving average of €361.75 and the 100-day average of €325.05 both stand well above the current price, a configuration that classically defines a medium-term correction within a still-intact long-term uptrend. The annualised 30-day volatility of 73.19% underscores just how jittery trading has become.
For the bulls, the case rests on the underlying business momentum. OHB’s order intake has surged, and its involvement in long-duration programmes such as IRIS² provides a multi-year revenue stream that is not easily disrupted. The company also welcomed a recent announcement by Defence Minister Boris Pistorius that the government is examining expanded launch capabilities for carrier rockets — though a final decision remains pending, and no contract value has been assigned.
The bearish camp counters that the overhang from the capital increase has not yet cleared. Trading persistently below the €300 placement price suggests that institutional buyers have not stepped in with sufficient conviction to absorb the newly issued stock. If that interpretation is correct, further selling pressure could emerge from holders who acquired shares at the placement and now find themselves underwater. The 32.97% gap between the current price and the 50-day moving average is the kind of divergence that, in overheated growth stocks, often signals that the correction has further to run.
OHB SE at a turning point? This analysis reveals what investors need to know now.
The 200-day line at €241.40 is therefore more than a technical curiosity. It represents the boundary between the euphoric first half of the year and a far more sober second act. A sustained hold above that level would favour the stabilisation narrative, allowing the capital-markets-driven correction to gradually burn itself out. A decisive break below it, however, would open the path toward the year’s lows and raise uncomfortable questions about whether the rearmament premium has evaporated entirely.
The next major catalyst is the third-quarter interim report, expected later this year. It will offer the first comprehensive look at how the enlarged equity base has affected OHB’s per-share metrics — and whether the operational story can once again take centre stage. Until then, the stock remains hostage to the technical tug-of-war between a fading bull narrative and a supply glut that the market has yet to fully digest.
Ad
OHB SE Stock: New Analysis - 28 July
Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
